| 1 | MAPK9
|
| MAPK9 is Correlated with a Poor Prognosis and Tumor Progression in Glioma.
|
| Yang X, Jia Q, Liu X, Wu W, Han Y, Zou Z, Li M, Fan D, Song J, Chen L.
|
| Front Biosci (Landmark Ed). Mar 28;28(3):63. doi: 10.31083/j.fbl2803063 2023
|
| 2 | MAPK9, RXRA
|
| Phosphorylation of RXRα mediates the effect of JNK to suppress hepatic FGF21 expression and promote metabolic syndrome.
|
| Vernia S, Lee A, Kennedy NJ, Han MS, Isasa M, Cavanagh-Kyros J, Roy A, Syed A, Chaudhry S, Edwards YJK, Gygi SP, Gao G, Davis RJ.
|
| Proc Natl Acad Sci U S A. Nov;119(44):e2210434119. doi: 10.1073/pnas.2210434119. Epub 2022 Oct 25. 2022
|
| 3 | CAMK2D, MAPK8, MAPK9
|
| Transcriptional regulation of stress kinase JNK2 in pro-arrhythmic CaMKIIδ expression in the aged atrium
|
| Gao X, Wu X, Yan J, Zhang J, Zhao W, DeMarco D, Zhang Y, Bakhos M, Mignery G, Sun J, Li Z, Fill M, Ai X.
|
| Cardiovasc Res. Apr 1;114(5):737-746. doi: 10.1093/cvr/cvy011. 2018
|
| 4 | AURKA, MAPK8, MAPK9, WDR62
|
| Opposing roles for JNK and Aurora A in regulating the association of WDR62 with spindle microtubules.
|
| Lim NR, Yeap YY, Zhao TT, Yip YY, Wong SC, Xu D, Ang CS, Williamson NA, Xu Z, Bogoyevitch MA, Ng DC.
|
| J Cell Sci 128(3):527-40.
2015
|
| 5 | MAPK8, MAPK9, TNFRSF1B, XPNPEP3
|
| Aminopeptidase P3, a new member of the TNF-TNFR2 signaling complex, induces phosphorylation of JNK1 and JNK2.
|
| Inoue M, Kamada H, Abe Y, Higashisaka K, Nagano K, Mukai Y, Yoshioka Y, Tsutsumi Y, Tsunoda S.
|
| J Cell Sci 128(4):656-69. doi: 10.1242/jcs.149385. Epub 2015 Jan 20. 2015
|
| 6 | IRS2, MAPK8, MAPK9, MAPK9
|
| JNK3 maintains expression of the insulin receptor substrate 2 (IRS2) in insulin-secreting cells: functional consequences for insulin signaling.
|
| Abdelli S, Bonny C.
|
| PLoS One 7(5):e35997. doi: 10.1371/journal.pone.0035997. Epub 2012 May 1.
2012
|
| 7 | MAPK8, MAPK9
|
| Requirement of c-Jun NH(2)-terminal kinase for Ras-initiated tumor formation.
|
| Cellurale C, Sabio G, Kennedy NJ, Das M, Barlow M, Sandy P, Jacks T, Davis RJ.
|
| Mol Cell Biol 31(7):1565-76. Epub 2011 Jan 31.
2011
|
| 8 | MAPK9
|
| JNK2 participates in spindle assembly during mouse oocyte meiotic maturation.
|
| Huang X, Tong JS, Wang ZB, Yang CR, Qi ST, Guo L, Ouyang YC, Quan S, Sun QY, Qi ZQ, Huang RX, Wang HL.
|
| Microsc Microanal 17(2):197-205. Epub 2011 Jan 31.
2011
|
| 9 | EPS8, MAPK9
|
| c-Jun N-terminal kinase 2 (JNK2) enhances cell migration through epidermal growth factor substrate 8 (EPS8).
|
| Mitra S, Lee JS, Cantrell M, Van den Berg CL.
|
| J Biol Chem 286(17):15287-97. Epub 2011 Feb 28.
2011
|
| 10 | MAPK9
|
| Molecular cloning and characterization of novel human JNK2 (MAPK9) transcript variants that show different stimulation activities on AP-1.
|
| Wang P, Xiong Y, Ma C, Shi T, Ma D.
|
| BMB Rep 43(11):738-43.
2010
|
| 11 | MAPK10, MAPK9
|
| Hippocampal c-Jun-N-terminal kinases serve as negative regulators of associative learning.
|
| Sherrin T, Blank T, Hippel C, Rayner M, Davis RJ, Todorovic C.
|
| J Neurosci 30(40):13348-61.
2010
|
| 12 | MAPK9
|
| c-Jun NH2-terminal kinase-2 mediates osmotic stress-induced tight junction disruption in the intestinal epithelium.
|
| Samak G, Suzuki T, Bhargava A, Rao RK.
|
| Am J Physiol Gastrointest Liver Physiol 299(3):G572-84. Epub 2010 Jul 1.
2010
|
| 13 | MAPK8, MAPK9
|
| JNK1 and JNK2 differently regulate IL-12 production in THP-1 macrophage cells.
|
| Utsugi M, Dobashi K, Ono A, Ishizuka T, Hisada T, Koga Y, Shimizu Y, Kawata T, Matsuzaki S, Aoki H, Kamide Y, Mori M.
|
| Cytokine 51(2):127-31. Epub 2010 May 18.
2010
|
| 14 | MAPK9
|
| The c-Jun NH2-terminal kinase 2 plays a dominant role in human epidermal neoplasia.
|
| Ke H, Harris R, Coloff JL, Jin JY, Leshin B, Miliani de Marval P, Tao S, Rathmell JC, Hall RP, Zhang JY.
|
| Cancer Res 70(8):3080-8. Epub 2010 Mar 30.
2010
|
| 15 | MAPK8, MAPK9
|
| Involvement of the c-jun N-terminal kinases JNK1 and JNK2 in complement-mediated cell death.
|
| Gancz D, Donin N, Fishelson Z.
|
| Mol Immunol 47(2-3):310-7. Epub 2009 Oct 27.
2009
|
| 16 | MAPK9
|
| Constitutive activity of JNK2 alpha2 is dependent on a unique mechanism of MAPK activation.
|
| Nitta RT, Chu AH, Wong AJ.
|
| J Biol Chem 283(50):34935-45. Epub 2008 Oct 21.
2008
|
| 17 | ALDH1L1, MAPK8, MAPK9
|
| Cooperation between JNK1 and JNK2 in activation of p53 apoptotic pathway.
|
| Oleinik NV, Krupenko NI, Krupenko SA.
|
| Oncogene 26(51):7222-30. Epub 2007 May 21.PMID: 17525747 2007
|
| 18 | RP1, MAPK8, MAPK9, MAPK10, MAP2K4 , MAP2, JUN
|
| Distinct gene expression profiles and reduced JNK signaling in retinitis pigmentosa caused by RP1 mutations.
|
| Liu J, Huang Q, Higdon J, Liu W, Xie T, Yamashita T, Cheon K, Cheng C, Zuo J.
|
| Hum Mol Genet 14(19):2945-58. Epub 2005 Aug 26. 2005
|
| 19 | MAPK8, MAPK9
|
| The c-Jun NH2-terminal kinase is essential for epidermal growth factor expression during epidermal morphogenesis.
|
| Weston CR, Wong A, Hall JP, Goad ME, Flavell RA, Davis RJ.
|
| Proc Natl Acad Sci U S A 101(39):14114-9. Epub 2004 Sep 16. 2004
|
| 20 | MAPK9, PDB3, SQSTM1
|
| Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone.
|
| Laurin N, Brown JP, Morissette J, Raymond V.
|
| Am J Hum Genet 70(6):1582-8. 2002
|